A combination of CD34 selection and complement-mediated immunopurging (anti-CD15 monoclonal antibody) eliminates tumor cells while sparing normal progenitor cells.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples